TherapeuticsMD, Inc. TXMD
1.71 USD -0.11 (-6.04%)
At closeNov 5, 2026, 4:00 PM EST
1.71 0.00 0.00%
After hours · Nov 5, 4:00 PM ET
1.71 Day range 1.82
1.18 52-week range 2.95
- YTD
- +4.91%
- 1 year
- +43.70%
News
defenseworld.net TherapeuticsMD (NASDAQ:TXMD) and Tilray Brands (NASDAQ:TLRY) Financial Review TherapeuticsMD (NASDAQ: TXMD - Get Free Report) and Tilray Brands (NASDAQ: TLRY - Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Nuwellis (NASDAQ:NUWE) stock increased by 27.2% to $1.22 during Wednesday's pre-market session. The market value of their outstanding shares is at $3.0 million. Summit Therapeutics…
benzinga.com TherapeuticsMD Q2 EPS $0.01 Down From $0.05 YoY, Sales $869.000K Down From $952.000K YoY TherapeuticsMD (NASDAQ:TXMD) reported quarterly earnings of $0.01 per share. This is a 80 percent decrease over earnings of $0.05 per share from the same period last year. The company reported…
gurufocus.com TherapeuticsMD Announces Second Quarter 2026 Financial Results TherapeuticsMD, Inc. (âTherapeuticsMDâ or the âCompanyâ) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financia
businesswire.com TherapeuticsMD Announces Second Quarter 2026 Financial Results BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results…
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session 
benzinga.com TherapeuticsMD Says Company Continues To Evaluate Strategic Alternatives, Including Acquisition Or Merger The Company continues to evaluate a variety of strategic alternatives that may include, but are not limited to, an acquisition, merger, other business combination, sale of assets, or other strategic…
benzinga.com TherapeuticsMD Q1 EPS $0.01 Up From $(0.06) YoY, Sales $724.000K Up From $393.000K YoY TherapeuticsMD (NASDAQ:TXMD) reported quarterly earnings of $0.01 per share. This is a 116.67 percent increase over losses of $(0.06) per share from the same period last year. The company reported…
businesswire.com TherapeuticsMD Announces First Quarter 2026 Financial Results BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results…
benzinga.com TherapeuticsMD Q4 EPS $(0.06) Down From $0.01 YoY, Sales $893.000K Up From $667.000K YoY TherapeuticsMD (NASDAQ:TXMD) reported quarterly losses of $(0.06) per share. This is a 700 percent decrease over earnings of $0.01 per share from the same period last year. The company reported…
businesswire.com TherapeuticsMD Announces Full Year 2025 Financial Results BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session 
businesswire.com TherapeuticsMD Announces Third Quarter 2025 Financial Results BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results…
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session 
businesswire.com TherapeuticsMD Announces Second Quarter 2025 Financial Results BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results…
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session 
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session - benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session
businesswire.com TherapeuticsMD Announces First Quarter 2025 Financial Results BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results…
businesswire.com TherapeuticsMD Announces Full Year 2024 Financial Results BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results…
benzinga.com Why GameStop Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket 
benzinga.com TherapeuticsMD And 2 Other Stocks Under $2 Executives Are Buying The Dow Jones index closed higher by more than 450 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects.
benzinga.com TherapeuticsMD And 2 Other Stocks Under $2 Executives Are Buying 
businesswire.com TherapeuticsMD Announces First Quarter 2024 Financial Results BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results…
businesswire.com TherapeuticsMD Announces Full Year 2023 Financial Results BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results…
businesswire.com TherapeuticsMD Announces Third Quarter 2023 Financial Results BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results…- benzinga.com Stocks That Hit 52-Week Lows On Thursday During the session on Thursday, 461 stocks hit new 52-week lows.
businesswire.com TherapeuticsMD Announces Second Quarter 2023 Financial Results BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results…
businesswire.com TherapeuticsMD Announces First Quarter 2023 Financial Results BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results…- businesswire.com TherapeuticsMD Announces First Quarter 2023 Financial Results BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results…
zacks.com All You Need to Know About TherapeuticsMD (TXMD) Rating Upgrade to Buy TherapeuticsMD (TXMD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
businesswire.com TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results…
businesswire.com TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results…
businesswire.com TherapeuticsMD Completes Transaction to License Its Products to Mayne Pharma BOCA RATON, Fla.--( BUSINESS WIRE )--TherapeuticsMD, Inc. (NASDAQ: TXMD) (“TherapeuticsMD,” “TXMD” or the “Company”), an innovative, leading women's healthcare company, today announced that it has…- benzinga.com Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday Gainers Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility.
- benzinga.com Why Viridian Therapeutics Is Trading Higher By Around 58%, Here Are 67 Stocks Moving In Monday's Mid-Day Session Gainers Sunrise New Energy Co. Ltd. (NASDAQ: EPOW) shares jumped 118.2% to $4.4948. Sunrise New Energy said that the company changed its name from Global Internet of the People, Inc. to Sunrise New…
- benzinga.com Earnings Scheduled For August 15, 2022 Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter.
- benzinga.com Why Revlon Shares Jumped 90%; Here Are 83 Biggest Movers From Yesterday Gainers Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPB) shares jumped 187.3% to close at $48.03 on Monday after gaining around 18% on Friday.
- benzinga.com U.S. Stocks Turn Negative; Dow Drops Over 100 Points U.S. stocks turned lower toward the end of trading, with the Dow Jones falling more than 100 points on Monday.
- benzinga.com This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday Gainers Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11,…
- benzinga.com Alibaba, Zoom Video And 76 Biggest Movers From Yesterday Gainers Kaspien Holdings Inc. (NASDAQ: KSPN) shares climbed 161.9% to close at $6.81 on Monday on heavy volume amid mention of the stock on social media.
- benzinga.com 77 Biggest Movers From Yesterday Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) shares climbed 364% to close at $9.93 on Tuesday after the company announced it has entered into a definitive merger agreement to be acquired by an…
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com 40 Stocks Moving In Tuesday's Mid-Day Session Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) shares jumped 360.8% to $9.86 after the company announced it has entered into a definitive merger agreement to be acquired by an affiliate of EW Healthcare…- benzinga.com 71 Biggest Movers From Yesterday Gainers CynergisTek, Inc. (NYSE: CTEK) shares surged 100% to close at $1.18 on Tuesday after the company entered into a definitive agreement to be acquired by Clearwater Compliance for roughly $17.7…
- benzinga.com 66 Biggest Movers From Friday Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) shares surged 90.2% to settle at $1.39 on Friday. GeoVax Labs, last month, said its Q1 sales results were lower year over year.
- benzinga.com Mid-Day Market Update: Dow Tumbles 200 Points; TherapeuticsMD Shares Jump U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 200 points on Friday.
- benzinga.com 38 Stocks Moving In Friday's Mid-Day Session Gainers Leju Holdings Limited (NYSE: LEJU) surged 27.8% to $4.0413.
- benzinga.com Mid-Morning Market Update: Markets Open Higher; Deere Tops Q2 Views U.S. stocks traded higher this morning. Following the market opening Friday, the Dow traded up 0.20% to 31,316.89 while the NASDAQ rose 0.35% to 11,428.90. The S&P also rose, gaining, 0.34% to…
- benzinga.com Earnings Scheduled For May 16, 2022 Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand.